Evidence map›Paper›PMID 40741342›Full record

ArticleComputational and structural biotechnology journal2025

Leveraging MDS2 and SBOM data for LLM-assisted vulnerability analysis of medical devices.

Stefan Stein, Michael Pilgermann, Simon Weber, Martin Sedlmayr

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Stefan SteinDepartment of Computer Science and Media, Brandenburg University of Applied Sciences, Magdeburger Straße 50, Brandenburg an der Havel, 14770, Brandenburg, Germany.
Michael PilgermannDepartment of Computer Science and Media, Brandenburg University of Applied Sciences, Magdeburger Straße 50, Brandenburg an der Havel, 14770, Brandenburg, Germany.
Simon WeberDepartment of Computer Science, Heinrich-Heine-University Dusseldorf, Universitätsstraße 1, Düsseldorf, 40225, North Rhine-Westphalia, Germany.
Martin SedlmayrInstitute for Medical Informatics and Biometry, Dresden University of Technology, Fetscherstraße 74, Dresden, 01307, Saxony, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the use of a semi-automated, Retrieval-Augmented Generation (RAG)-based multi-agent architecture to analyze security-relevant data and assemble specialized exploitation paths targeting medical devices. The input dataset comprised device-specific sources, namely, the Manufacturer Disclosure Statement for Medical Device Security (MDS2) documents and Software Bills of Materials (SBOMs), enriched with public vulnerability databases, including Common Vulnerabilities and Exposures (CVE), Known Exploited Vulnerabilities (KEV), and Metasploit exploit records. The objective was to assess whether a modular, Large Language Model (LLM)-driven agent system could autonomously correlate device metadata with known vulnerabilities and existing exploit information to support structured threat modeling. The architecture follows a static RAG design based on predefined prompts and fixed retrieval logic, without autonomous agent planning or dynamic query adaptation. The developed Vulnerability Intelligence for Threat Analysis in Medical Security (VITAMedSec) system operates under human-prompted supervision and successfully synthesizes actionable insights and exploitation paths without requiring manual step-by-step input during execution. Although technically coherent results were obtained under controlled conditions, real-world validation remains a critical avenue for future research. This study further discusses the dual-use implications of such an agent-based framework, its relevance to patient safety in medical device cybersecurity, and the broader applicability of the proposed architecture to other critical infrastructure sectors. These findings emphasize both the technical potential and ethical responsibility for applying semi-automated AI workflows in medical cybersecurity contexts.

Indexed as

Cyber securityIT securityLarge Language Model (LLM)Manufacturer disclosure statement for medical device securityMDS2Medical cyber-physical systemsMedical deviceMedical information systemOperational technology (OT) securityVulnerabilities

Identifiers

PMID40741342
PMCPMC12309023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.